secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001640334-25-001046
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences completes 1-for-6 reverse stock split; Nasdaq compliance regained
--------------------------------------------------------------------------------

- Effective 12:01 a.m. ET June 13, 2025; each 6 pre-split shares combine into 1 post-split share; outstanding shares reduced from 3,280,000 to ~546,667.
- Authorized common shares reduced from 50M to 8,333,333; preferred authorized reduced from 416,667 to 69,444.
- New CUSIP: 04301G607. No fractional shares; holders receive one whole share for any fractional entitlement.
- Warrants adjust: each 6 pre-split warrants (exercise $0.75) combine into 1 warrant exercisable at $4.50 per post-split share.
- Nasdaq confirmed on June 13, 2025 that ARTL regained compliance with the $1.00 minimum bid price requirement; deficiency matter closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/0001640334-25-001046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer